Metformin is an oral antidiabetic drug in the biguanide class, which is used for type 2 diabetes. The side effects of metformin are mostly limited to digestive tract symptoms, such as diarrhea, flatulence and abdominal discomfort. The most serious potential adverse effect of metformin is lactic acidosis. A 51-year-old man was admitted due to hypoglycemia as a result of an overdose of antidiabetic drugs. He took massive dose of metformin. Conservative treatment failed for metabolic acidosis without lactic acidosis accompanied by acute kidney injury. Hemodialysis was executed to correct the high anion gap metabolic acidosis and acute kidney injury, and the patient recovered fully from metabolic acidosis. This case illustrates that the presenc...
Metformin intoxication with lactic acidosis, a potentially lethal condition, may develop in diabetic...
Metformin is a widely used antihyperglycemic agent recommended by both the American Diabetes Associa...
OBJECI1VE: To document a case of anion gap, nonketotic metabolic acidosis occurring in a patient wit...
Metformin is an oral antidiabetic drug in the biguanide class, which is used for type 2 diabetes. Th...
Metformin is an oral antidiabetic from biguanide class and is the first-line treat...
Metformin is commonly used in the treatment of type 2 diabetes mellitus (DM). Severe lactic acidosis...
Metformin is a biguanide commonly used in type 2 diabetes mellitus (DM). Lactic acidosis, a potentia...
Metformin is a biguanide used in the treatment of type 2 diabetic patients with normal renal functio...
Metformin, the only biguanide available in France, is a widely prescribed anti-diabetic agent. It im...
PubMedID: 24299454Metformin is a biguanide group oral antidiabetic drug used for the treatment of ty...
Metformin is recommended as a first-line treatment for patients with diabetes mellitus type 2; it ha...
BACKGROUND: Lactic acidosis in metformin use is a widely recognised but rare side effect. Case repor...
Metformin, a widely used anti-diabetic agent of the biguanide family, although generally safe holds ...
Metformin, a molecule belonging to the biguanide family, represents one of the most commonly prescri...
Metformin (MF) accumulation during acute kidney injury is associated with high anion gap lactic acid...
Metformin intoxication with lactic acidosis, a potentially lethal condition, may develop in diabetic...
Metformin is a widely used antihyperglycemic agent recommended by both the American Diabetes Associa...
OBJECI1VE: To document a case of anion gap, nonketotic metabolic acidosis occurring in a patient wit...
Metformin is an oral antidiabetic drug in the biguanide class, which is used for type 2 diabetes. Th...
Metformin is an oral antidiabetic from biguanide class and is the first-line treat...
Metformin is commonly used in the treatment of type 2 diabetes mellitus (DM). Severe lactic acidosis...
Metformin is a biguanide commonly used in type 2 diabetes mellitus (DM). Lactic acidosis, a potentia...
Metformin is a biguanide used in the treatment of type 2 diabetic patients with normal renal functio...
Metformin, the only biguanide available in France, is a widely prescribed anti-diabetic agent. It im...
PubMedID: 24299454Metformin is a biguanide group oral antidiabetic drug used for the treatment of ty...
Metformin is recommended as a first-line treatment for patients with diabetes mellitus type 2; it ha...
BACKGROUND: Lactic acidosis in metformin use is a widely recognised but rare side effect. Case repor...
Metformin, a widely used anti-diabetic agent of the biguanide family, although generally safe holds ...
Metformin, a molecule belonging to the biguanide family, represents one of the most commonly prescri...
Metformin (MF) accumulation during acute kidney injury is associated with high anion gap lactic acid...
Metformin intoxication with lactic acidosis, a potentially lethal condition, may develop in diabetic...
Metformin is a widely used antihyperglycemic agent recommended by both the American Diabetes Associa...
OBJECI1VE: To document a case of anion gap, nonketotic metabolic acidosis occurring in a patient wit...